Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep

Singanallur, N. B.; Pacheco, J. M.; Arzt, J.; Stenfeldt, C.; Fosgate, G. T.; Rodriguez, L.; Vosloo, W.

doi:10.1016/j.antiviral.2017.07.020

Title: Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep

Full Record
Other Related Research

Authors:: Singanallur, N. B.; Pacheco, J. M.; Arzt, J.; Stenfeldt, C.; Fosgate, G. T.; Rodriguez, L.; Vosloo, W.

Publication Date:: 2017-09-01

Sponsoring Org.:: USDOE

OSTI Identifier:: 1549806

Resource Type:: Publisher's Accepted Manuscript

Journal Name:: Antiviral Research

Additional Journal Information:: Journal Name: Antiviral Research Journal Volume: 145 Journal Issue: C; Journal ID: ISSN 0166-3542

Publisher:: Elsevier

Country of Publication:: Netherlands

Language:: English

Citation Formats


                    Singanallur, N. B., Pacheco, J. M., Arzt, J., Stenfeldt, C., Fosgate, G. T., Rodriguez, L., and Vosloo, W. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep.  Netherlands: N. p., 2017. 
        Web.  doi:10.1016/j.antiviral.2017.07.020.

Copy to clipboard


                    Singanallur, N. B., Pacheco, J. M., Arzt, J., Stenfeldt, C., Fosgate, G. T., Rodriguez, L., & Vosloo, W. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep.  Netherlands.  doi:https://doi.org/10.1016/j.antiviral.2017.07.020

Copy to clipboard


                    Singanallur, N. B., Pacheco, J. M., Arzt, J., Stenfeldt, C., Fosgate, G. T., Rodriguez, L., and Vosloo, W. Fri .  
        "Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep".  Netherlands.  doi:https://doi.org/10.1016/j.antiviral.2017.07.020.

Copy to clipboard


                    
@article{osti_1549806,

  title        = {Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep},

  author       = {Singanallur, N. B. and Pacheco, J. M. and Arzt, J. and Stenfeldt, C. and Fosgate, G. T. and Rodriguez, L. and Vosloo, W.},

  abstractNote = {},

  doi          = {10.1016/j.antiviral.2017.07.020},

  journal      = {Antiviral Research},

  number       = C,

  volume       = 145,

  place        = {Netherlands},

  year         = {2017},

  month        = {9}

}

Copy to clipboard

Journal Article:

Free Publicly Available Full Text

Accepted Manuscript (Publisher)

Publisher's Version of Record
DOI: https://doi.org/10.1016/j.antiviral.2017.07.020

Other availability

Search WorldCat to find libraries that may hold this journal

Citation Metrics:

Cited by: 1 work

Citation information provided by
Web of Science

Save / Share:

Export Metadata

Save to My Library

Similar Records in DOE PAGES and OSTI.GOV collections:

Multiple efficacy studies of an adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle using homologous challenge

Journal Article Schutta, Christopher ; Barrera, José ; Pisano, Melia ; ... - Vaccine

Here, the safety and efficacy of an experimental, replication-deficient, human adenovirus-vectored foot-and-mouth disease virus (FMDV) serotype A24 Cruzeiro capsid-based subunit vaccine (AdtA24) was examined in eight independent cattle studies. AdtA24 non-adjuvanted vaccine was administered intramuscularly to a total of 150 steers in doses ranging from approximately 1.0 × 10⁸ to 2.1 × 10¹¹ particle units per animal. No detectable local or systemic reactions were observed after vaccination. At 7 days post-vaccination (dpv), vaccinated and control animals were challenged with FMDV serotype A24 Cruzeiro via the intradermal lingual route. Vaccine efficacy was measured by FMDV A24 serum neutralizing titers and bymore »« less
Cited by 12
DOI: https://doi.org/10.1016/j.vaccine.2015.12.018
Clinical and virological dynamics of a serotype O 2010 South East Asia lineage foot-and-mouth disease virus in sheep using natural and simulated natural inoculation and exposure systems

Journal Article Stenfeldt, Carolina ; Pacheco, Juan M. ; Singanallur, Nagendrakumar B. ; ... - Veterinary Microbiology
Cited by 7
DOI: https://doi.org/10.1016/j.vetmic.2015.04.004
Adenovirus-vectored foot-and-mouth disease vaccine confers early and full protection against FMDV O1 Manisa in swine

Journal Article Fernandez-Sainz, Ignacio ; Medina, Gisselle N. ; Ramirez-Medina, Elizabeth ; ... - Virology
Cited by 5
DOI: https://doi.org/10.1016/j.virol.2016.12.021
Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine

Journal Article Barrera, José ; Schutta, Christopher ; Pisano, Melia ; ... - Vaccine

A foot-and-mouth disease (FMD) recombinant subunit vaccine formulated with a lipid/polymer adjuvant was evaluated in two vaccine efficacy challenge studies in steers. The vaccine active ingredient is a replication-deficient human adenovirus serotype 5 vector encoding the FMD virus (FMDV) A24/Cruzeiro/BRA/55 capsid (AdtA24). In the first study, AdtA24 formulated in ENABL® adjuvant was compared to a fourfold higher dose of AdtA24 without adjuvant. Steers vaccinated with AdtA24 + ENABL® adjuvant developed a significantly higher virus neutralizing test (VNT) antibody titer and an improved clinical response following FMDV A24/Cruzeiro/BRA/55 intradermal lingual challenge at 14 days post-vaccination (dpv) than steers vaccinated with themore »« less
Cited by 9
DOI: https://doi.org/10.1016/j.vaccine.2018.01.026
Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission model

Journal Article Neilan, John G. ; Schutta, Christopher ; Barrera, José ; ... - BMC Veterinary Research

A direct contact transmission challenge model was used to simulate natural foot-and-mouth disease virus (FMDV) spread from FMDV A24/Cruzeiro/BRA/55 infected ‘seeder’ steers to naïve or vaccinated steers previously immunized with a replication-deficient human adenovirus-vectored FMDV A24/Cruzeiro/BRA/55 capsid-based subunit vaccine (AdtA24). In two independent vaccine efficacy trials, AdtA24 was administered once intramuscularly in the neck 7 days prior to contact with FMDV A24/Cruzeiro/BRA/55-infected seeder steers.
Cited by 2
DOI: https://doi.org/10.1186/s12917-018-1582-1

Similar Records